Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
183 | 3 | NOONAN SYNDROME//PTEN//CELL BIOLOGY | 56293 |
1549 | 2 | RAS//FARNESYLTRANSFERASE//RAL | 7653 |
3262 | 1 | FARNESYLTRANSFERASE//FARNESYLTRANSFERASE INHIBITOR//PROTEIN FARNESYLTRANSFERASE | 2058 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | FARNESYLTRANSFERASE | authKW | 983067 | 5% | 61% | 106 |
2 | FARNESYLTRANSFERASE INHIBITOR | authKW | 501658 | 3% | 61% | 54 |
3 | PROTEIN FARNESYLTRANSFERASE | authKW | 416872 | 2% | 83% | 33 |
4 | FARNESYLTRANSFERASE INHIBITORS | authKW | 397498 | 2% | 58% | 45 |
5 | PROTEIN PRENYLATION | authKW | 345832 | 2% | 47% | 48 |
6 | LONAFARNIB | authKW | 300109 | 1% | 70% | 28 |
7 | PRENYLATION | authKW | 277685 | 4% | 23% | 79 |
8 | TIPIFARNIB | authKW | 267524 | 2% | 56% | 31 |
9 | FARNESYL TRANSFERASE INHIBITOR | authKW | 230714 | 2% | 42% | 36 |
10 | GERANYLGERANYLTRANSFERASE | authKW | 209980 | 1% | 57% | 24 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 7348 | 18% | 0% | 373 |
2 | Biochemistry & Molecular Biology | 5594 | 44% | 0% | 906 |
3 | Oncology | 1770 | 17% | 0% | 348 |
4 | Chemistry, Organic | 1399 | 13% | 0% | 269 |
5 | Cell Biology | 597 | 11% | 0% | 218 |
6 | Biochemical Research Methods | 441 | 6% | 0% | 119 |
7 | Biophysics | 384 | 6% | 0% | 123 |
8 | Pharmacology & Pharmacy | 217 | 9% | 0% | 177 |
9 | Hematology | 166 | 4% | 0% | 73 |
10 | Mycology | 29 | 1% | 0% | 13 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | KENTUCKY STRUCT BIOL | 138275 | 1% | 53% | 17 |
2 | ANTICANC PROGRAM | 45938 | 0% | 100% | 3 |
3 | DRUG DISCOVERY PROGRAM | 40032 | 2% | 6% | 44 |
4 | GLENOLDEN | 31789 | 0% | 23% | 9 |
5 | PROGRAM CANC STEM CELL BIOL | 30736 | 1% | 13% | 15 |
6 | LUTTE CONTRE CANC CLAUDIUS REGAUD | 30625 | 0% | 100% | 2 |
7 | ZENTRUM PHARMAFOR | 23259 | 1% | 8% | 18 |
8 | EA GRIIOT 4481 | 21426 | 0% | 20% | 7 |
9 | MEMBRANE MOLEC BIOL | 20415 | 0% | 67% | 2 |
10 | PROGRAM PROTEASES | 20415 | 0% | 67% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 9890 | 6% | 1% | 130 |
2 | JOURNAL OF MEDICINAL CHEMISTRY | 2958 | 3% | 0% | 66 |
3 | JOURNAL OF BIOLOGICAL CHEMISTRY | 2821 | 8% | 0% | 174 |
4 | BIOORGANIC & MEDICINAL CHEMISTRY | 2445 | 2% | 0% | 47 |
5 | METHODS IN ENZYMOLOGY | 2032 | 2% | 0% | 48 |
6 | BIOCHEMISTRY | 1937 | 4% | 0% | 85 |
7 | CLINICAL CANCER RESEARCH | 909 | 2% | 0% | 31 |
8 | MEDCHEMCOMM | 811 | 0% | 1% | 9 |
9 | CANCER RESEARCH | 617 | 2% | 0% | 42 |
10 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | 541 | 0% | 0% | 9 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |